India's Shilpa Medicare jumps after FDA clears Bengaluru unit
16/07/2025 06:51
** Shares of Shilpa Medicare SHME.NS climb 4.5% to 932.6 rupees; set for best day in about 2 months ** Pharma co says U.S. FDA issues voluntary action indicated (VAI) classification for a Bengaluru facility ** VAI classification implies that the facility will not face any regulatory action ** YTD, stock up 14% so far (Reporting by Manvi Pant in Bengaluru) ((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026